Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3146646
Reference Type
Journal Article
Title
LB01.11: PREVALENCE OF SECONDARY HYPERTENSION IN YOUNG HYPERTENSIVE ADULTS
Author(s)
Camelli, S; Bobrie, G; Postel-Vinay, N; Azizi, M; Plouin, PF; Amar, L
Year
2015
Is Peer Reviewed?
1
Journal
Journal of Hypertension
ISSN:
0263-6352
EISSN:
1473-5598
Volume
33 Suppl 1
Page Numbers
e47
Language
English
PMID
26102832
DOI
10.1097/01.hjh.0000467473.21331.70
Abstract
OBJECTIVE:
Data from referral centers suggest that approximately 10% of hypertensive patients could have secondary hypertension (2HTN). It is commonly accepted that 2HTN is more frequent in younger subjects but its prevalence is not known.
DESIGN AND METHOD:
Retrospective analysis of the computerized medical records of consecutive hypertensive patients aged 18 to 40 years referred to the Georges Pompidou ESH hypertension center who underwent in-hospital work-up including renal artery duplex ultrasound or CT angiography, determination of plasma aldosterone/renin ratio and 24 h urinary metanephrine.
RESULTS:
Between January 2008 and December 2013, 843 patients (52.2% women) aged 26.9 ± 6.2 years were referred to our center. 509 patients (60.4%) had a family history of hypertension and 356 (42.4%) had a body mass index exceeding 27 kg/m. BP levels were 142.0/89.2 mmHg with a median number of 1 (range 0-7) antihypertensive drugs. 250 patients (29.6%) were diagnosed with 2HTN including primary aldosteronism in 62 patients (7.4 %), fibromuscular dysplasia in 49(5.8%) and pheochromocytoma in 33 (3.9%) patients.
CONCLUSIONS:
Before the age of 40, the prevalence of 2HTN is close to 30%. This high prevalence confirms the necessity of a systematic work-up for 2HTN in younger adults. Further analysis will aim to identify the phenotype based on the cause of hypertension.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity